Julia A. Wang

Executive Vice President, Chief Financial Officer (Principal Financial Officer), Labcorp

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Julia A. Wang signed the annual report of Labcorp as Executive Vice President, Chief Financial Officer (Principal Financial Officer); the report was filed on February 24, 2026, the most recent filing in the record that ties Julia A. Wang to the seat.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
Labcorp (LH) Services-Medical Laboratories	Executive Vice President, Chief Financial Officer (Principal Financial Officer)	In the seat	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

February 24, 202610-K filed
Julia A. Wang signed the annual report of Labcorp on Form 10-K as Executive Vice President, Chief Financial Officer (Principal Financial Officer), filed February 24, 2026.
/s/ JULIA A. WANG Executive Vice President, Chief Financial Officer Julia A. Wang (Principal Financial Officer)
[1] Annual report on Form 10-K by Labcorp, filed with the SEC on February 24, 2026. Read the filing. The record at CFO Tribune.

Sources

Annual report on Form 10-K, Labcorp. U.S. Securities and Exchange Commission, EDGAR, filed February 24, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Julia A. Wang wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.